Followers | 274 |
Posts | 56398 |
Boards Moderated | 24 |
Alias Born | 08/29/2007 |
Sunday, July 23, 2023 3:20:33 PM
GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ME News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 09:05:59 PM
- 23andMe Regains Compliance With Nasdaq Listing Requirements • GlobeNewswire Inc. • 10/30/2024 09:00:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/29/2024 08:27:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:06:54 PM
- 23andMe Appoints Three New Independent Directors to Board • GlobeNewswire Inc. • 10/29/2024 11:30:00 AM
- 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South • GlobeNewswire Inc. • 10/17/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:21:00 PM
- 23andMe Announces Completion of 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 10/16/2024 12:15:00 PM
- 23andMe Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 10/11/2024 12:15:00 PM
- 23andMe Announces Mathew Knowles as New Brand Ambassador • GlobeNewswire Inc. • 10/08/2024 11:00:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/30/2024 08:58:24 PM
- 23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating • GlobeNewswire Inc. • 09/25/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:39:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/18/2024 12:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:05:52 PM
- Meta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates Spectacles • IH Market News • 09/18/2024 10:13:07 AM
- Independent Directors of 23andMe Resign from Board • GlobeNewswire Inc. • 09/17/2024 08:26:04 PM
- 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial • GlobeNewswire Inc. • 09/15/2024 07:00:00 AM
- 23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study • GlobeNewswire Inc. • 09/15/2024 07:00:00 AM
- One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations • GlobeNewswire Inc. • 09/12/2024 08:05:00 PM
- Norfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition Proposals • IH Market News • 09/12/2024 10:02:29 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/11/2024 08:45:16 PM
- 23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:32:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2024 08:31:26 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM